Communiqués Rapid Dose Therapeutics Corp. OTC Markets

Actions

RDTCF

CA75339A1012

Equipement, fournitures et distribution médicale

Temps Différé OTC Markets 15:30:00 03/09/2026			Varia. 5j.	Varia. 1 janv.
0,0850 ^USD	0,00 %		0,00 %	-5,56 %

30/07	Rapid Dose Therapeutics Corp. publie ses résultats pour le premier trimestre clos le 31 mai 2026	CI
29/07	Rapid Dose Therapeutics Corp et Bodhi Health Inc étendent la distribution et la vente de la curcumine CurcuWIN QuickStrip à travers le Canada	CI

Communiqués

20/08	Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy	NE
28/07	Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada	NE
11/07	Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt	NE
07/07	Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization	NE
13/04	Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets	NE
06/04	Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt	NE
26/03	Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory	NE
05/03	Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market	NE
23/02	Rapid Dose Therapeutics : Advances Cannabinoid Research and Clinical Evaluation of QuickStrip™ Platform	PU
23/02	Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform	NE
11/02	Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors	NE
10/02	Rapid Dose Therapeutics Launches QuickStrip(TM) Medical Cannabis for Patients in Brazil following ANVISA Approval of Sublingual and Buccal Formats for Medical Treatment	NE
05/01	Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt	NE
09/12	Rapid Dose Completes Extension to Promissory Notes	NE
29/11	Rapid Dose Announces Extension to Promissory Notes	NE
18/11	Rapid Dose Therapeutics : NicStrip™ Featured in CEO Interview	PU
18/11	CEO.CA's Inside the Boardroom: Rapid Dose Therapeutics Extends NicStrip(TM) Deal with Nicotine Partner as Health Canada Reviews Product	NE
20/10/25	Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner	NE
02/10/25	Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt	NE
04/08/25	Rapid Dose Therapeutics Submits QuickStrip(TM) Nicotine Product for Health Canada Approval	NE
29/07/25	Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip(TM) to Combat Opiate Addiction Crisis	NE
22/07/25	CEO.CA's Inside the Boardroom: QuickStrip Technology - How Rapid Dose Is Changing The Way We Take Medicine	NE
03/07/25	Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt	NE
03/07/25	Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees	NE
02/07/25	CEO.CA's Inside the Boardroom: Rapid Dose's Drug Delivery Tech in NFL-Funded Study	NE